NCT01588353View on ClinicalTrials.gov

Collagenase Option for Reduction of Dupuytren's Contracture in Japan

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Dupuytren's Contracture
Interventions
DRUG

Collagenase Clostridium Histolyticum

AK160 (Collagenase Clostridium Histolyticum) 0.58 mg

Trial Locations (20)

Unknown

Aichi

Aomori

Chiba

Fukuoka

Hiroshima

Hokkaido

Ishikawa

Kanagawa

Kumamoto

Kyoto

Mie

Nagano

Nagasaki

Niigata

Numakunai

Okayama

Osaka

Tokushima

Tokyo

Yamaguchi

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT01588353 - Collagenase Option for Reduction of Dupuytren's Contracture in Japan | Biotech Hunter | Biotech Hunter